Johnson & Johnson：Akeega®Niraparib and Abiraterone Acetate Tabletsapproved for marketing in China.
Antengene：Announces Exclusive License Agreement with K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE
BioMap and Harbour BioMed：Announce Landmark Strategic Partnership
Everest：Announces Exclusive Commercialization Licensing Agreement with Dimerix Limited
Lilly：4E Therapeutics, Inc. Announces Acquisition by Eli Lilly and Company
AstraZeneca：ULTOMIRIS®Ravulizumab marketing application submitted in the United States.
Sanofi：Sarclisa®Isatuximabwas approved for marketing inJapan
GSK：Utebzi™Tebipenem Pivoxilwas approved for marketing in the United States.
How much does Somatuline Autogel (Lanreotide Acetate Sustained-release Injection) Cost& price without insurance in China?
How much does Sandostatin LAR (Octreotide Acetate Microspheres for Injection) Cost& price without insurance in China?
